| National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the medical expenditure panel survey JA Salami, H Warraich, J Valero-Elizondo, ES Spatz, NR Desai, JS Rana, ... JAMA cardiology 2 (1), 56-65, 2017 | 363 | 2017 |
| Race, racism, and cardiovascular health: applying a social determinants of health framework to racial/ethnic disparities in cardiovascular disease Z Javed, M Haisum Maqsood, T Yahya, Z Amin, I Acquah, ... Circulation: Cardiovascular Quality and Outcomes 15 (1), e007917, 2022 | 159 | 2022 |
| Trends in differences in health status and health care access and affordability by race and ethnicity in the United States, 1999-2018 S Mahajan, C Caraballo, Y Lu, J Valero-Elizondo, D Massey, ... Jama 326 (7), 637-648, 2021 | 148 | 2021 |
| Cost-related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2017 R Khera, J Valero-Elizondo, SR Das, SS Virani, BA Kash, JA De Lemos, ... Circulation 140 (25), 2067-2075, 2019 | 122 | 2019 |
| Association of subjective and objective sleep duration as well as sleep quality with non-invasive markers of sub-clinical cardiovascular disease (CVD): a systematic review M Aziz, SS Ali, S Das, A Younus, R Malik, MA Latif, C Humayun, ... Journal of atherosclerosis and thrombosis 24 (3), 208-226, 2017 | 116 | 2017 |
| Social determinants of health and cardiovascular disease: current state and future directions towards healthcare equity MH Jilani, Z Javed, T Yahya, J Valero-Elizondo, SU Khan, B Kash, ... Current atherosclerosis reports 23, 1-11, 2021 | 98 | 2021 |
| Gender differences in patient‐reported outcomes among adults with atherosclerotic cardiovascular disease V Okunrintemi, J Valero‐Elizondo, B Patrick, J Salami, M Tibuakuu, ... Journal of the American Heart Association 7 (24), e010498, 2018 | 95 | 2018 |
| Patient–provider communication and health outcomes among individuals with atherosclerotic cardiovascular disease in the United States: Medical Expenditure Panel Survey 2010 to 2013 V Okunrintemi, ES Spatz, P Di Capua, JA Salami, J Valero-Elizondo, ... Circulation: Cardiovascular Quality and Outcomes 10 (4), e003635, 2017 | 88 | 2017 |
| Association of out-of-pocket annual health expenditures with financial hardship in low-income adults with atherosclerotic cardiovascular disease in the United States R Khera, J Valero-Elizondo, V Okunrintemi, A Saxena, SR Das, ... JAMA cardiology 3 (8), 729-738, 2018 | 86 | 2018 |
| Financial toxicity in atherosclerotic cardiovascular disease in the United States: current state and future directions R Khera, J Valero-Elizondo, K Nasir Journal of the American Heart Association 9 (19), e017793, 2020 | 82 | 2020 |
| Financial hardship from medical bills among nonelderly US adults with atherosclerotic cardiovascular disease J Valero-Elizondo, R Khera, A Saxena, GR Grandhi, SS Virani, J Butler, ... Journal of the American College of Cardiology 73 (6), 727-732, 2019 | 65 | 2019 |
| Burden and consequences of financial hardship from medical bills among nonelderly adults with diabetes mellitus in the United States C Caraballo, J Valero-Elizondo, R Khera, S Mahajan, GR Grandhi, ... Circulation: Cardiovascular Quality and Outcomes 13 (2), e006139, 2020 | 60 | 2020 |
| Economic impact of moderate‐vigorous physical activity among those with and without established cardiovascular disease: 2012 Medical Expenditure Panel Survey J Valero‐Elizondo, JA Salami, CU Osondu, O Ogunmoroti, A Arrieta, ... Journal of the American Heart Association 5 (9), e003614, 2016 | 59 | 2016 |
| Association of income disparities with patient-reported healthcare experience V Okunrintemi, R Khera, ES Spatz, JA Salami, J Valero-Elizondo, ... Journal of general internal medicine 34, 884-892, 2019 | 57 | 2019 |
| Variation and disparities in awareness of myocardial infarction symptoms among adults in the United States S Mahajan, J Valero-Elizondo, R Khera, NR Desai, R Blankstein, ... JAMA network open 2 (12), e1917885-e1917885, 2019 | 55 | 2019 |
| Estimates of mortality benefit from ideal cardiovascular health metrics: a dose response meta‐analysis EC Aneni, A Crippa, CU Osondu, J Valero‐Elizondo, A Younus, K Nasir, ... Journal of the American Heart Association 6 (12), e006904, 2017 | 54 | 2017 |
| Social determinants of health and obesity: Findings from a national study of US adults Z Javed, J Valero‐Elizondo, MH Maqsood, S Mahajan, MB Taha, KV Patel, ... Obesity 30 (2), 491-502, 2022 | 51 | 2022 |
| Favorable cardiovascular risk profile is associated with lower healthcare costs and resource utilization: the 2012 Medical Expenditure Panel Survey J Valero-Elizondo, JA Salami, O Ogunmoroti, CU Osondu, EC Aneni, ... Circulation: Cardiovascular Quality and Outcomes 9 (2), 143-153, 2016 | 48 | 2016 |
| Out‐of‐pocket annual health expenditures and financial toxicity from healthcare costs in patients with heart failure in the United States SY Wang, J Valero‐Elizondo, HJ Ali, A Pandey, M Cainzos‐Achirica, ... Journal of the American Heart Association 10 (14), e022164, 2021 | 45 | 2021 |
| Absence of coronary artery calcification in middle-aged familial hypercholesterolemia patients without atherosclerotic cardiovascular disease R Mszar, GR Grandhi, J Valero-Elizondo, SS Virani, R Blankstein, ... Cardiovascular Imaging 13 (4), 1090-1092, 2020 | 42 | 2020 |
Khurram NasirChief CV Prevention/Wellness Houston Methodist, Professor of Medicine Weill CornellDirección de correo verificada de houstonmethodist.org
